or Try an Advanced Search...

    Technical Analysis for NPCE - Neuropace, Inc.

    Grade Last Price % Change Price Change
    C 8.94 -2.77% -0.26
    NPCE closed up 0.11 percent on Wednesday, November 20, 2024, on 33 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical NPCE trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction -2.77%
    Inside Day Range Contraction -2.77%
    Wide Bands Range Expansion -2.77%
    Calm After Storm Range Contraction -2.67%
    Upper Bollinger Band Walk Strength -2.67%
    Wide Bands Range Expansion -2.67%
    Calm After Storm Range Contraction -0.17%
    Upper Bollinger Band Walk Strength -0.17%
    Inside Day Range Contraction -0.17%
    Wide Bands Range Expansion -0.17%
    Older End-of-Day Signals for NPCE ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 2 hours ago
    Down 2 % about 2 hours ago
    Down 1% about 2 hours ago
    60 Minute Opening Range Breakout 2 days ago
    Up 3% 2 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NPCE Chart by TradingView
    Basic chart:

    Profile

    NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Neuroscience Epilepsy Neuromodulation Neurophysiology Neurotechnology Electroencephalography Seizure Neuroprosthetics

    Is NPCE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 What Makes NeuroPace (NPCE) a New Buy Stock
    Nov 18 Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade
    Nov 14 NeuroPace Third Quarter 2024 Earnings: Beats Expectations
    Nov 12 Earnings Scheduled For November 12, 2024
    Nov 9 private equity firms who own 45% along with institutions invested in NeuroPace, Inc. (NASDAQ:NPCE) saw increase in their holdings value last week
    Nov 4 NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
    Oct 16 NeuroPace Continues to Strengthen Management Team
    Sep 4 NeuroPace Strengthens Management Team with Two Key Appointments
    Aug 27 NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
    Aug 16 Earnings Release: Here's Why Analysts Cut Their NeuroPace, Inc. (NASDAQ:NPCE) Price Target To US$14.57
    See more NPCE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 18.15
    52 Week Low 5.45
    Average Volume 78,599
    200-Day Moving Average 9.50
    50-Day Moving Average 7.05
    20-Day Moving Average 7.54
    10-Day Moving Average 8.46
    Average True Range 0.79
    RSI (14) 67.43
    ADX 23.54
    +DI 30.04
    -DI 18.17
    Chandelier Exit (Long, 3 ATRs) 8.04
    Chandelier Exit (Short, 3 ATRs) 7.83
    Upper Bollinger Bands 9.90
    Lower Bollinger Band 5.18
    Percent B (%b) 0.85
    BandWidth 62.64
    MACD Line 0.68
    MACD Signal Line 0.46
    MACD Histogram 0.225
    Fundamentals Value
    Market Cap 241.55 Million
    Num Shares 26.3 Million
    EPS -1.49
    Price-to-Earnings (P/E) Ratio -6.17
    Price-to-Sales 6.99
    Price-to-Book 27.16
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.24
    Resistance 3 (R3) 10.17 9.75 10.07
    Resistance 2 (R2) 9.75 9.48 9.79 10.01
    Resistance 1 (R1) 9.47 9.32 9.26 9.54 9.95
    Pivot Point 9.05 9.05 8.95 9.09 9.05
    Support 1 (S1) 8.77 8.78 8.56 8.84 8.43
    Support 2 (S2) 8.35 8.62 8.38 8.37
    Support 3 (S3) 8.07 8.35 8.31
    Support 4 (S4) 8.14